Monday, June 15, 2026

New Grand Koleos Drives Renault Korea to Its Best March in Years

Renault Korea's Grand Koleos SUV debuted at the Busan Mobility Show, boosting March sales by 15.7% driven by domestic demand.

T+1 Settlement Revolution: How Korea’s Exchange Plans to Lead Asia

The Korea Exchange plans to shorten the stock market settlement cycle to T+1 through international due diligence visits to New York and London.

KOSPI and KOSDAQ Rebound: How Trump’s Tariff Threats Impacted South Korea’s Stock Market

KOSPI opens lower amid U.S. market volatility; Trump's tariff comments stir uncertainty, affecting investor behavior and stock performance.

Tag: biotechnology

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Samjin Pharm Selected as Leading Biotech Firm in Government-Backed ‘World Class Plus’ Project

Samjin Pharm selected for the "World Class Plus Project" to enhance global competitiveness in biotech with innovative drug developments.

How SCL Science’s Digital Logistics Platform BIONECT is Revolutionizing the Cold Chain Industry

SCL Science showcased its next-gen bio-logistics platform at the Korea Cold Chain 2026, emphasizing advanced cold chain logistics for healthcare.

Top 3 Innovative Korean Biotech Firms Shine at Novo Nordisk Partnering Day 2026

Novo Nordisk Korea hosted Partnering Day 2026 to foster global partnerships in healthcare, highlighting innovative local biotech firms.

Unlocking the Future of Cancer Treatment: UCI-101 CAR-NK Therapy by UCI Therapeutics

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

AI in Healthcare: How Lunit and KAIST Are Revolutionizing Medical Technology in 2026

South Korea enhances AI in healthcare with Lunit and KAIST's models, achieving high accuracy and speed for medical applications.

ABL Bio to Invest Additional $25 Million in Neok Bio to Accelerate ADC Clinical Trials

ABL Bio invests $25M in Neok Bio for bispecific antibody-drug conjugate trials, aiming for FDA-approved treatments by 2027.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

Matica Biotechnologies Signs Adenovirus Therapy CDMO Deal With North American Research Institution

CHA Biotech's U.S. subsidiary, Matica Biotechnologies, secures a CDMO agreement for adenovirus therapy with a major North American institution.

NovaCell Technology Passes KOSDAQ Evaluation: What This Means for DongKoo BioPharm’s Future

Donggu Bio Pharmaceutical announces that its invested company, Novacell Technologies, has passed the technical evaluation for KOSDAQ listing.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

Curiosis: Revolutionizing Bio Research with Automated Cell Imaging Systems

Curiosis enhances biomedical research with automated cell analysis, aiming for profitability and becoming a leading lab automation provider.

HLB BioStep Signs Strategic MOU with CLIPS BnC… Toward Integrated Preclinical and Clinical Development

HLB BioStep and CLIPS BnC sign MOU to enhance collaboration between preclinical and clinical stages of drug development.

GCCell Secures Groundbreaking Patent for Next-Gen Cell Therapy: What It Means for the Future of Immunotherapy

GC Cell has completed the registration of core technology patents for next-gen cell and gene therapies in South Korea and Japan.

Can AI Speed Up Drug R&D?: PharmGen Science Teams With Polaris AI Pharma Across the Full Development Cycle

PharmGen Science partners with Polaris AI Pharma to enhance drug development using AI technologies and optimize R&D processes.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.